[Clinical use of Rigevidon, Ovidon and Postinor].
D000328:Adult; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000627:therapeutic use*; D003281:Contraceptives, Postcoital / Q000009:adverse effects / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000009:adverse effects / Q000627:therapeutic use*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000188:drug therapy; D009644:Norgestrel / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000188:drug therapy
D003276:Contraceptives, Oral; D003281:Contraceptives, Postcoital; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination
Klinicheskoe ispol'zovanie rigevidona, ovidona i postinora.